Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Investing

Eli Lilly : LLY

All Eli Lilly Articles

688 Articles

Jon C. Ogg | Oct 24, 2017 at 12:25 PM EDT

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

Jon C. Ogg | Oct 18, 2017 at 2:10 PM EDT

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 10, 2017 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Alphabet, Check Point Software, Chesapeake Energy, Chevron, Intel,…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 7, 2017 at 10:35 AM EDT

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Eli Lilly is cutting about 8% of its global workforce in a "streamlining and focusing" effort as part of a…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jul 26, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

The top analyst upgrades, downgrades and other research calls from Wednesday include BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald's,…

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 25 26 27 28 29 … 46

Eli Lilly : LLY

All Eli Lilly Articles

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

Major Pharma Short Interest Takes a Big Step Back

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

That Quantum Fund Is Up 40% in 2026 and Just Crossed $6 Billion. The Field Keeps Beating the Stock-Pickers

She Inherited Her Sister’s IRA at 69 and Emptied It in One Year. Medicare Billed Her as Though She’d Earned It.

2 Million Kids Got Free SpaceX Shares in Their Trump Accounts, So What Are They Worth Now?

She Inherited Her Sister's IRA at 69 and Emptied It in One Year. Medicare Billed Her as Though She'd Earned It.

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

That Quantum Fund Is Up 40% in 2026 and Just Crossed $6 Billion. The Field Keeps Beating the Stock-Pickers

She Inherited Her Sister’s IRA at 69 and Emptied It in One Year. Medicare Billed Her as Though She’d Earned It.

Eli Lilly : LLY

All Eli Lilly Articles

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

Major Pharma Short Interest Takes a Big Step Back

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

That Quantum Fund Is Up 40% in 2026 and Just Crossed $6 Billion. The Field Keeps Beating the Stock-Pickers

She Inherited Her Sister’s IRA at 69 and Emptied It in One Year. Medicare Billed Her as Though She’d Earned It.

2 Million Kids Got Free SpaceX Shares in Their Trump Accounts, So What Are They Worth Now?

Featured Reads

She Inherited Her Sister's IRA at 69 and Emptied It in One Year. Medicare Billed Her as Though She'd Earned It.

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.